Gen İlaç Ve Sağlik Ürünleri A.ş.

This study is testing whether a new oral drug called SUL-238 can improve the energy function of brain cells in people with early, untreated Parkinson's disease. Researchers will compare two doses of SUL-238 against a placebo in 45 participants over a 28-day treatment period. The …